Table 1 Characteristics of the kidney transplant cohort at one-month post-transplantation

Age at transplant (years)

49 (40, 59)

 White

112 (75 %)

 Black

34 (23 %)

 Other

3 (2 %)

Sex (male)

111 (74 %)

BMI

27.3 (23.5, 30.5)

 Never

77 (52 %)

 Current

14 (9 %)

 Former

58 (39 %)

Pack Years

11.5 (3, 24.0)

Cardiovascular disease^a

59 (40 %)

Diabetes

56 (38 %)

Hypertension

142 (95 %)

Hyperlipidemia

83 (56 %)

Months on Dialysis pre-transplant

20.3 (6.9, 47.2)

 Vascular Disease

78 (52 %)

 Glomerular Disease

31 (21 %)

 Tubulointerstitial Disease

9 (6 %)

 Cystic Disease

19 (13 %)

 Structure Disease

1 (1 %)

 Renal Neoplasia

1 (1 %)

 Other

10 (7 %)

Estimated Glomerular Filtration Rate (ml/min/m²)

58 (48, 69)

Mean Arterial Pressure (mm Hg)

95.7 (87.3, 103.7)

 Alemtuzumab

134 (90 %)

 Basiliximab

14 (9 %)

 Anti-Thymocyte Globulin

1 (1 %)

 Tacrolimus

146 (98 %)

 Mycophenolate

143 (96 %)

 Prednisone

81 (54 %)

 Alpha Blockers

11 (7 %)

 Beta Blockers

88 (59 %)

 Calcium Channel Blockers

77 (52 %)

 ACE^b Inhibitors

4 (3 %)

 Angiotensin Receptor Blocker

4 (3 %)

 Vasodilators

6 (4 %)

Statin Therapy

29 (20 %)

Slow Graft Function

23 (16 %)

Delayed Graft Function

8 (5 %)